Sarda Proteins Ltd (519242) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 519242 | NSE: | Edible Oil | Small Cap

Sarda Proteins Share Price

75 -3.60 -4.58%
as on 05-Dec'25 16:59

Sarda Proteins Ltd (519242) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 519242 | NSE: | Edible Oil | Small Cap

DeciZen - make an informed investing decision on Sarda Proteins

Based on:

M-Cap below 100cr DeciZen not available

Sarda Proteins stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
12.9 Cr.
52-wk low:
60
52-wk high:
144.3

Is Sarda Proteins Ltd an attractive stock to invest in?

1. Is Sarda Proteins Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Sarda Proteins Ltd is a below average quality company.

2. Is Sarda Proteins Ltd undervalued or overvalued?

The key valuation ratios of Sarda Proteins Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Sarda Proteins Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sarda Proteins Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Sarda Proteins:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Sarda Proteins Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -4.5%-6%-14.9%-3.9%8.4%3%15.8%0.6%0.8%0.9%-
Value Creation
Index
-1.3-1.4-2.1-1.3-0.4-0.80.1-1.0-0.9-0.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 2.16.25.77.25.411.410.85.81.324.239
Sales YoY Gr.-200%-8.6%27.8%-25.2%110.4%-5.3%-46.1%-77.6%1,760.8%-
Adj EPS -0.7-0.8-1.8-0.80.2-0.11.8-0.20.10-0.6
YoY Gr.-NANANANA-163.2%NA-110.6%NA-72.7%-
BVPS (₹) 10.910.18.27.57.77.59.39.19.29.38.8
Adj Net
Profit
-0.1-0.1-0.3-0.10-00.3-000-0
Cash Flow from Ops. -1.2-0.10.5-0.6-0.1-0.10.1-0.3-0.2-0.1-
Debt/CF from Ops. -0.5-2.10-0000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 31.5%35%31%1760.8%
Adj EPS NA-30.9%-74.4%-72.7%
BVPS-1.7%3.9%-0.2%0.3%
Share Price 32.5% 51.2% -20.8% -30.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-4.4-5.1-13.1-6.81.6-113.9-1.40.80.2-6.8
Op. Profit
Mgn %
-3.6-2.7-5.7-1.41.8-0.22.5-2.5-11.30.1-0.3
Net Profit
Mgn %
-5.8-2.1-5.5-20.6-0.22.9-0.61.50-0.3
Debt to
Equity
0.20.100000000-
Working Cap
Days
390148113761165663127601350
Cash Conv.
Cycle
19597914753261770-20

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 31.00%

Sales growth is good in last 4 quarters at 1294.11%

Return on Equity is Poor

Latest Financials - Sarda Proteins Ltd.

Standalone Consolidated
TTM EPS (₹) -0.6 -
TTM Sales (₹ Cr.) 39.3 -
BVPS (₹.) 8.8 -
Reserves (₹ Cr.) - -
P/BV 8.58 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 59.95 / 144.30
All Time Low / High (₹) 4.40 / 330.70
Market Cap (₹ Cr.) 12.9
Equity (₹ Cr.) 1.7
Face Value (₹) 10
Industry PE 42.1

Management X-Ray of Sarda Proteins:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Sarda Proteins - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Sarda Proteins

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales2.066.185.657.225.4011.3610.765.801.3024.19
Operating Expenses 2.196.346.017.325.3011.3810.495.941.4424.17
Manufacturing Costs0.070.180.330.01000000
Material Costs1.735.785.167.025.1310.9810.295.721.2123.91
Employee Cost 0.110.100.120.120.090.120.130.130.150.07
Other Costs 0.270.280.390.180.080.280.080.090.090.19
Operating Profit -0.12-0.16-0.35-0.100.10-0.020.27-0.15-0.150.02
Operating Profit Margin (%) -6.0%-2.7%-6.3%-1.4%1.8%-0.2%2.5%-2.5%-11.3%0.1%
Other Income 0000.030.080.080.090.160.170
Interest 0.030.0100000000
Depreciation 0.020.010.010.01000000
Exceptional Items 000000-0000
Profit Before Tax -0.17-0.19-0.37-0.090.170.060.350.010.020.02
Tax -0.01-0.06-0.040.040.140.080.050.05-00.02
Profit After Tax -0.15-0.13-0.33-0.120.03-0.020.31-0.030.020.01
PAT Margin (%) -7.5%-2.1%-5.9%-1.7%0.6%-0.2%2.9%-0.6%1.5%0.0%
Adjusted EPS (₹)-0.9-0.8-1.9-0.70.2-0.11.8-0.20.10.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 2.652.522.192.072.102.082.392.352.372.38
Share Capital 2.502.502.502.502.502.502.502.502.502.50
Reserves 0.150.02-0.31-0.44-0.41-0.43-0.12-0.15-0.13-0.13
Minority Interest0000000000
Debt0.600.2000.01000000
Long Term Debt0000000000
Short Term Debt0.600.2000.01000000
Trade Payables00.0100000000.22
Others Liabilities -0.14-0.21-0.31-0.29-0.25-0.17-0.11-0.08-0.07-0.07
Total Liabilities 3.112.511.881.791.851.912.272.272.302.53

Fixed Assets

Gross Block0.250.250.230.230.090.090000
Accumulated Depreciation0.190.200.200.210.090.090000
Net Fixed Assets 0.060.050.030.020.010.010000
CWIP 0000000000
Investments 0.010.010.010000000
Inventories1.591.050.430000000
Trade Receivables00.660.690.720.830.770.21000
Cash Equivalents 0.250.240.540.070.100.130.330.180.120.03
Others Assets 1.200.500.180.980.9111.742.082.182.49
Total Assets 3.112.511.881.791.851.912.272.272.302.53

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -1.20-0.090.48-0.59-0.05-0.050.10-0.30-0.23-0.11
PBT -0.17-0.19-0.37-0.090.170.060.350.010.020.02
Adjustment -0.060.030.01-0.09-0.07-0.08-0.08-0.16-0.16-0
Changes in Working Capital -0.970.070.83-0.41-0.12-0.02-0.17-0.15-0.09-0.13
Tax Paid 000.010-0.03-0.010000
Cash Flow From Investing Activity 0.20-00.020.110.090.080.090.160.170
Capex 0.02-0-000.0100000
Net Investments 0000.01000000
Others 0.1800.020.100.080.080.090.160.160
Cash Flow From Financing Activity 0.37-0.42-0.200.01-0.01-0-00-00.03
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing -0.01000000000.03
Interest Paid -0.03-0.01-0-0-0-0-00-00
Dividend Paid 0000000000
Others 0.41-0.40-0.200.01-0.0100000
Net Cash Flow -0.63-0.510.30-0.470.030.030.19-0.14-0.07-0.08

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-6.67-7.31-20.98-9.152.52-1.5521.15-2.081.230.32
ROCE (%)-4.5-5.96-14.89-3.928.38315.810.550.80.86
Asset Turnover Ratio0.72.22.573.942.976.045.152.550.5710.02
PAT to CFO Conversion(x)N/AN/AN/AN/A-1.67N/A0.32N/A-11.5-11
Working Capital Days
Receivable Days0394436532617000
Inventory Days17978480000000
Payable Days1000000003

Sarda Proteins Ltd Stock News

Sarda Proteins Ltd FAQs

The current trading price of Sarda Proteins on 05-Dec-2025 16:59 is ₹75.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Sarda Proteins stood at ₹12.94.
The latest P/E ratio of Sarda Proteins as of 04-Dec-2025 is 0.00.
The latest P/B ratio of Sarda Proteins as of 04-Dec-2025 is 8.58.
The 52-week high of Sarda Proteins is ₹144.3 and the 52-week low is ₹59.95.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sarda Proteins is ₹39.31 ( Cr.) .

About Sarda Proteins Ltd

Sarda Proteins was incorporated in 1991 for manufacturing and marketing of mustard oil. The company is based at Alwar in Rajasthan.

The company received certificate of commencement of Business on December 17, 1991. Later the company had acquired 18000 square metres in the industrial estate of Bhiwadi in Alwar district Rajasthan and started civil work on the same.

The company is having some associate companies namely, Sarda Agro Products, Sarda Oil Industries, Sarda Industrial Corporation, and Aura Infracons.

In the year 2008, company appointed Siddharth Sarda as whole time director of the Company for a period of 5 years with effect from August 01, 2008.

Company’s registered office is located at E-172 (A) Matsya Industrial Area, Alwar, Rajasthan - 301030

You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×